A proposal to fund clinical studies in low income countries has just been proposed by MGHI and accepted by the Lancet. This letter to the editor written by 3 MGHI members (Eddy Pasquier, Brendan Guercio and Nicolas André, is entitled "Investment in cancer studies in countries of low and middle income". You can read it in the attached file or on the Lancet website here. This proposal relies on establishing a system of incentives and obligations for pharmaceutical companies as performed in Europe and the USA for the development of drugs for children.